BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14719100)

  • 1. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma.
    Li XL; Eishi Y; Bai YQ; Sakai H; Akiyama Y; Tani M; Takizawa T; Koike M; Yuasa Y
    Int J Oncol; 2004 Feb; 24(2):257-63. PubMed ID: 14719100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior.
    Yao T; Tsutsumi S; Akaiwa Y; Takata M; Nishiyama K; Kabashima A; Tsuneyoshi M
    Jpn J Cancer Res; 2001 Jul; 92(7):755-61. PubMed ID: 11473726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.
    Hütz K; Mejías-Luque R; Farsakova K; Ogris M; Krebs S; Anton M; Vieth M; Schüller U; Schneider MR; Blum H; Wagner E; Jung A; Gerhard M
    Carcinogenesis; 2014 Apr; 35(4):942-50. PubMed ID: 24325912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short history of pluripotent stem cells markers.
    Andrews PW; Gokhale PJ
    Stem Cell Reports; 2024 Jan; 19(1):1-10. PubMed ID: 38157849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KPT6566 induces apoptotic cell death and suppresses the tumorigenicity of testicular germ cell tumors.
    Sun R; Lee EJ; Lee S; Kim G; Kim J
    Front Cell Dev Biol; 2023; 11():1220179. PubMed ID: 38020885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.
    López L; Fernández-Vañes L; Cabal VN; García-Marín R; Suárez-Fernández L; Codina-Martínez H; Lorenzo-Guerra SL; Vivanco B; Blanco-Lorenzo V; Llorente JL; López F; Hermsen MA
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation.
    Zhu Z; Lin S; Wu X; Xu J; Li L; Ye W; Li J; Huang Z
    Onco Targets Ther; 2021; 14():623-636. PubMed ID: 33519210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma.
    Osman NAA; Khalil AI; Yousef RK
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2961-2970. PubMed ID: 33112555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.
    Wuputra K; Ku CC; Wu DC; Lin YC; Saito S; Yokoyama KK
    J Exp Clin Cancer Res; 2020 Jun; 39(1):100. PubMed ID: 32493501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p.
    Cui F; Hao ZX; Li J; Zhang YL; Li XK; He JX
    Mol Genet Genomic Med; 2020 May; 8(5):e1195. PubMed ID: 32130794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-Based SOX2-Promoter Methylation in Relation to Exercise and PM
    Su CL; Tantoh DM; Chou YH; Wang L; Ho CC; Chen PH; Lee KJ; Nfor ON; Hsu SY; Liang WM; Liaw YP
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.
    Wang P; Shang J; Zhao J; Wang K; Guo L; Gu J; Wang W
    Mol Med Rep; 2020 Mar; 21(3):1201-1207. PubMed ID: 31922212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAC1: biology and potential application in cancer immunotherapy.
    Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ghaffari-Tabrizi-Wizsy N; Ostad SN; Zarnani AH
    Cancer Immunol Immunother; 2019 Jul; 68(7):1039-1058. PubMed ID: 31165204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Identification and Evolution Analysis of
    Jiang L; Bi D; Ding H; Wu X; Zhu R; Zeng J; Yang X; Kan X
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 31013663
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
    Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 interferes with the function of CDX2 in bile acid-induced gastric intestinal metaplasia.
    Yuan T; Ni Z; Han C; Min Y; Sun N; Liu C; Shi M; Lu W; Wang N; Du F; Wu Q; Xie N; Shi Y
    Cancer Cell Int; 2019; 19():24. PubMed ID: 30733645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2 is associated with cancer stem-like properties in colorectal cancer.
    Takeda K; Mizushima T; Yokoyama Y; Hirose H; Wu X; Qian Y; Ikehata K; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Sci Rep; 2018 Dec; 8(1):17639. PubMed ID: 30518951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BORIS: a key regulator of cancer stemness.
    Soltanian S; Dehghani H
    Cancer Cell Int; 2018; 18():154. PubMed ID: 30323717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.